Navigation Links
Malaria vaccine prompts victims' immune system to eliminate parasite from mosquitoes

ren each year. The disease can result in severe headache, high fever, chills, and vomiting. Malaria is caused by a single celled parasite, Plasmodium. In all, four species of Plasmodium cause malaria in people, with Plasmodium falciparum causing the most severe form. The malarial parasite spends part of its life cycle in humans, and part in mosquitoes. The parasite is injected into an individual by the bite of an infected mosquito. Numerous experimental vaccines have been tried against the form of the parasite that resides in humans, but have been unsuccessful or produced limited immunity. The Plasmodium cells escape the human immune system by hiding in liver and blood cells, making them difficult to target with a vaccine. During the human phase of the infection, these cells, for the most part, exist in an asexual form.

Some of the Plasmodium cells, however, transform into gametocytes—the sexual forms of the parasite that are equivalent to sperm and eggs. Fertilization takes place in the mosquito gut, after which the parasite imbeds itself in the gut lining. There, it passes through discrete stages, before migrating to the insect's salivary glands, where it is passed on to the next host through a mosquito bite.

The protein Pfs25 (Plasmodium falciparum surface protein 25) is found only on the surface of the ookinette, a stage of the parasite living in the mosquito gut, and does not appear on any other stage of the parasite. When injected into human volunteers, Pfs25 fails to generate a sufficient level of antibodies to target the parasite.

In their article, the researchers described several strategies for using conjugate technology to make an effective vaccine based on Pfs25. These consisted of chemically linking numerous Pfs25 molecules to each other and to other proteins: Pseudomonas aeruginosa exotoxin A, a protein from a species of bacteria that infects people with weakened immune systems, and ovalbumin, a protein found
'"/>

Source:NIH/National Institute of Child Health and Human Development


Page: 1 2 3

Related biology news :

1. Malaria mechanism revealed
2. Malaria killing a million a year
3. Malaria parasites develop in lymph nodes
4. Malaria, potato famine pathogen share surprising trait
5. Twenty Years of Malaria Research: Outcomes and Perspectives
6. Malaria treatment efficacy compromised in certain HIV-positive patients
7. Malaria may fuel spread of HIV in sub-Saharan Africa
8. Research advances quest for HIV-1 vaccine
9. A much-needed shot in the arm for HIV vaccine development
10. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
11. Gene vaccine for Alzheimers disease shows promising results

Post Your Comments:
(Date:11/4/2009)...ember 4, 2009 Childhood obesity in the United Sta...an one fourth of advertising on daytime and prime ... continuing questions about the role television pl...ssue of the Journal of Nutrition Education and Be...ldren might be a large contributor to the problem....
(Date:11/4/2009)... Oct. 20 Quest Diagnosti... provider of diagnostic testing, information and s...d September 30, 2009, income from continuing opera...hare, from $160 million, or $0.81 per diluted shar...uarter results were reduced by a $0.03 per share c...
(Date:11/4/2009)...t. 26 BIO-key Internatio...finger-based biometric identification software is ... the AABB TXPO conference being held at the New Or...IO-key will provide hands-on product demonstration...y in booth #424. Also, at 5 PM on Monday, October ...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17BIO-key(R) International Exhibiting at AABB TXPO 2RMACT Celebrates Seven Years of Growing Families 57136 1RMACT Celebrates Seven Years of Growing Families 57136 2RMACT Celebrates Seven Years of Growing Families 57136 3RMACT Celebrates Seven Years of Growing Families 57136 4Treating bone loss in breast cancer survivors 9926 1Treating bone loss in breast cancer survivors 9926 2Ecosystem researchers to hold science briefing for policymakers 9925 1
...n in yeast, worms, and flies keeps blood sugar und...ust Cell Metabolism. The findings suggest therapeu... of metabolic disorders, such as type 2 diabetes, ...aid. , The team found that mice with an excess of ...proved glucose tolerance and enhanced insulin secr...
...ired infections can persist for days and even week...ttings, including bed linens, computer keyboard co...h presented today at the 105th General Meeting of ...in-resistant Staphylococcus aureus (MRSA) is a maj...ited States. Staphylococcal infections can cause c...
...,s motor nerve cells grow along proper paths durin... inhibiting spinal-cord neurons from regenerating ...al Center have found. In cultured cells, the resea...ce that normally insulates and stabilizes long ner...the ability of nerve cells to grow through myelin ...
Other Biology News:Sea Ice May Be on Increase in the Antarctic 2Researchers find molecule that inhibits regrowth of spinal nerve cells 2Researchers find molecule that inhibits regrowth of spinal nerve cells 3
(Date:11/6/2009)...EO, Calif., Nov. 6 ,...transfer of Qutenza(TM) E.U. Marketing Authorizati...nt progress in commercial readiness activities Ex... Director, Marketing; and Director, Commercial Ope... director and Audit Committee chairman , Up...
(Date:11/6/2009)..., Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biote...e "Company") today announced updated results from ...ients with sarcomas metastatic to the lung in a po...ssue Oncology Society Meeting held in Miami Beach,...sentation, entitled "A Phase II Study of Intraveno...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010...ich is set to take place on February 22-24, 2010 i...day conference we will highlight key issues in for...share their experiences. , ...agenda for Arrowhead’s 2010 Personalized Me...
(Date:11/5/2009)...SBURG, Md., Nov. 5 GenVe...cial results for the third quarter ended September...ion ($0.04 per share) for the three months ended S...illion ($0.08 per share) in the comparable quarter...2009, GenVec,s net loss was $14.1 million ($0.15 p...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... Biotech Ltd. (Amex:,SVA), a leading provider of v...h of Anflu(R), a seasonal influenza vaccine, for 2... Sinovac, Anflu(R) is the only split influenza,vac...vac is undertaking the,sales and marketing program...the adult dosage form of Anflu(R)., Utilizing the...
...ber 11 at 11:00 AM ET, WAYNE, Pa., Sept. 10 Enco...multinational clinical research organization,(CRO)...of the world,s,leading pharmaceutical and biotechn...nted Dr. David Ginsberg, Chief Executive Officer o...sition from Dr. Kai Lindevall, who,was named to th...
...ber of US clinics, CHICAGO, IL, Sept. 10 /PRNewsw...st commercially available bionic hand, today revea...8 National Assembly of the American,Orthotic and P...ovember 3,2008, the company,s RACE Team and Partne...rt to the growing number of prosthetics clinics th...
Other Biology Technology:Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season 2Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season 3Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 2Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 3Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 4Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 5Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 6Touch Bionics unveils innovative partner and reimbursement programs at AOPA 2Touch Bionics unveils innovative partner and reimbursement programs at AOPA 3
Rabbit Anti-D4-GDI Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-MAL Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human ADAM-12 (Meltrin alpha), amino terminal region Antibody, Unconjugated from CEDARLANE Laboratories Limited
Rabbit Anti-FLIP Polyclonal Antibody, Unconjugated from Abcam
Biology Products: